Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
GHK-Cu (Copper Peptide) REPORTS POSTED IN PRODUCT GALLERY Current Batch: 11019-004 Test Date April 9th 2026 Purity: 99.94% Net Content: 101.05mg Cap Color: Red Vial Size: 5mL Endotoxin Test: PASS ( Posted in the Product Gallery) All analyses are conducted for research purposes and performed in duplicate in accordance with USP guidelines
Vitamin B12 Toxicity Some people might worry that they are getting too much vitamin B12
-EC and GSH standards and UDE augmented BV-2 intracellular GSH content In our previous observations, we noted the anti-neuroinflammatory effect of a 4 h incubation with 100 M of -EC, GSH, or UDE containing 100 M -EC against the generation of proinflammatory cytokines induced by LPS
Your physician is here to help with any medical questions
IV therapy for general wellness in healthy people costs $100-400 per session, typically recommended monthly